Dr. Deepak Nagrath, a professor of biomedical engineering at the University of Michigan, has been awarded the prestigious Departmental Faculty Award, sponsored by the U-M College of Engineering. Nominated by the Biomedical Engineering (BME) department, Dr. Nagrath was recognized for his contributions to cancer metabolism research and his leadership in transcriptional medicine.
As a key member of the Center for Transcriptional Medicine (CTM), Dr. Nagrath collaborates with more than 40 researchers from seven universities to develop mRNA-LNP therapies aimed at treating end-stage organ diseases. The CTM fosters interdisciplinary research and accelerates clinical applications of innovative treatments.
His research focuses on understanding how the tumor microenvironment influences cancer cell metabolism, with the goal of developing personalized metabolic therapies. His lab employs advanced techniques such as machine learning, metabolic flux analysis, and systems metabolomics to model metabolic activity in pancreatic, lung, breast, and brain cancers.
Dr. Nagrath’s work was recently highlighted in the Illuminate magazine by the U-M Rogel Cancer Center, showcasing how his research is reshaping cancer treatment strategies. With expertise spanning biomedical engineering, oncology, and machine learning, his contributions continue to push the boundaries of cancer research and precision medicine.
The University of Michigan’s Biomedical Engineering program, a collaboration between the College of Engineering and the Medical School, offers world-class research and educational opportunities. Consistently ranked among the top public universities in the U.S., U-M remains at the forefront of innovation in biomedical sciences.
